Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/9193
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPapaioannou, A.en
dc.contributor.authorManos, M.en
dc.contributor.authorKarkabounas, S.en
dc.contributor.authorLiasko, R.en
dc.contributor.authorEvangelou, A. M.en
dc.contributor.authorCorreia, I.en
dc.contributor.authorKalfakakou, V.en
dc.contributor.authorPessoa, J. C.en
dc.contributor.authorKabanos, T.en
dc.date.accessioned2015-11-24T16:47:30Z-
dc.date.available2015-11-24T16:47:30Z-
dc.identifier.issn0162-0134-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/9193-
dc.rightsDefault Licence-
dc.subjectvanadiumen
dc.subjectcysteineen
dc.subjectantitumor activityen
dc.subjectcircular dichroismen
dc.subjectelectron paramagnetic resonanceen
dc.subjectcysteine methyl-esteren
dc.subjectvanadium complexesen
dc.subjectmalignant-tumorsen
dc.subjecthuman-plasmaen
dc.subjectwistar ratsen
dc.subjectenkephalinaseen
dc.subjectoxovanadium(iv)en
dc.subjectcrystalen
dc.subjectligandsen
dc.subjectepren
dc.titleSolid state and solution studies of a vanadium(III)-L-cysteine compound and demonstration of its antimetastatic, antioxidant and inhibition of neutral endopeptidase activitiesen
heal.typejournalArticle-
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.identifier.primaryDOI 10.1016/j.jinorgbio.2004.02.011-
heal.identifier.secondary<Go to ISI>://000221939000006-
heal.identifier.secondaryhttp://ac.els-cdn.com/S0162013404000479/1-s2.0-S0162013404000479-main.pdf?_tid=e92d71a88a90fbde7a7bb101aee49ee1&acdnat=1333030587_2836120f6674caa0a10d3d8621127930-
heal.languageen-
heal.accesscampus-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Θετικών Επιστημών. Τμήμα Χημείαςel
heal.publicationDate2004-
heal.abstractReaction of one equivalent of vanadium(III) chloride with three equivalents Of L-cysteine(H(2)Cys) in methyl alcohol affords a V-III-Cys compound that is formulated as [V-III(HCYS)(3)] . 2HCl . 2.5H(2)O 1. The solid state characterization of 1 was performed by microanalysis, circular dichroism (CD) and infrared studies as well as room temperature magnetic susceptibility. These studies have shown coordination of each HCys(-) ligand to the V-III atom through an amine nitrogen and a carboxylate oxygen atoms. Solution studies of I were carried out in water and methanol by UV visible, CD and electron paramagnetic resonance (EPR) spectroscopies. According to these studies, it was evident that despite the progressive oxidation of 1 to oxovanadium(IV) species, some V(III) species were also present in solution after several hours. Compound 1, (VOSO4)-O-IV.5H(2)O and L-cysteine were examined for their total antioxidant capacity (TAC) and lag time. Compound 1 exhibited significantly greater total antioxidant capacity and lag time values than L-cysteine. (VOSO4)-O-IV.5H(2)O did not show any total antioxidant capacity or lag time. The inhibition of neutral endopeptidase (NEP) activity caused by 1, (VOSO4)-O-IV . 5H(2)O and thiorphan was also measured. Compound 1, at a concentration of 10(-3) M, showed inhibition of NEP activity as potent as thiorphan at 10(-6) M, while (VOSO4)-O-IV . 5H(2)O in the same concentration exhibited less than 50% inhibitory activity than that of thiorphan at 10-6 M. Moreover, the antimetastatic effects of compound 1, L-CySteine and (VOSO4)-O-IV . 5H(2)O were examined on Wistar rats, treated with 3,4-benzopyrene. The results revealed that I prevents significantly lung metastases (only 9.5% of animals treated with 1 showed metastases), whereas 47-52% of the rats of the control group and those treated with L-cysteine and (VOSO4)-O-IV . 5H(2)O exhibited metastases. (C) 2004 Elsevier Inc. All rights reserved.en
heal.publisherElsevieren
heal.journalNameJ Inorg Biochemen
heal.journalTypepeer reviewed-
heal.fullTextAvailabilityTRUE-
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά). ΧΗΜ

Files in This Item:
File Description SizeFormat 
Papaioannou-2004-Solid state and solu.pdf299.77 kBAdobe PDFView/Open    Request a copy


This item is licensed under a Creative Commons License Creative Commons